Benzathine benzylpenicillin

From Self-sufficiency
Jump to: navigation, search
Benzathine benzylpenicillin
Combination of
Benzylpenicillin Antibiotic
Identifiers
CAS Number 54-35-3
ATC code J01CE08 (WHO)
PubChem CID 15232
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Benzathine benzylpenicillin (rINN) is a form of penicillin also known as benzathine penicillin. It is slowly absorbed into the circulation, after intramuscular injection, and hydrolysed to benzylpenicillin in vivo. It is the drug-of-choice when prolonged low concentrations of benzylpenicillin are required and appropriate, allowing prolonged antibiotic action over 2–4 weeks after a single IM dose. It is marketed by Wyeth under the trade name Bicillin L-A.

Specific indications for benzathine penicillin include:[1]

Toxicology

Compendial status

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

See also

Intracellular
inhibit peptidoglycan subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin) · DADAL/AR inhibitors (Cycloserine) · bactoprenol inhibitors (Bacitracin)
Glycopeptide
inhibit PG chain elongation: Vancomycin# (Oritavancin, Telavancin) · Teicoplanin (Dalbavancin) · Ramoplanin
β-lactams/
(inhibit PBP
cross-links)
Combinations
Other

M: BAC

drug(J1p, w, n, m, vacc)

hr:Benzatin penicilin

pl:Benzylopenicylina benzatynowa

pt:Benzilpenicilina benzatina
  1. ↑ Rossi S, editor, ed. (2006). Australian Medicines Handbook. Adelaide: Australian Medicines Handbook. ISBN 0-9757919-2-3. 
  2. ↑ British Pharmacopoeia Commission Secretariat. "Index (BP 2009)" (PDF). Retrieved 26 March 2010. 
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Benzathine_benzylpenicillin&oldid=8257"